Paul Bailey

1.6k total citations
44 papers, 1.3k citations indexed

About

Paul Bailey is a scholar working on Psychiatry and Mental health, Pharmacology and Behavioral Neuroscience. According to data from OpenAlex, Paul Bailey has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 9 papers in Behavioral Neuroscience. Recurrent topics in Paul Bailey's work include Stress Responses and Cortisol (9 papers), Schizophrenia research and treatment (8 papers) and Treatment of Major Depression (8 papers). Paul Bailey is often cited by papers focused on Stress Responses and Cortisol (9 papers), Schizophrenia research and treatment (8 papers) and Treatment of Major Depression (8 papers). Paul Bailey collaborates with scholars based in France, United States and Brazil. Paul Bailey's co-authors include Fabrice Duval, Marc‐Antoine Crocq, J.P. Macher, Marie‐Claude Mokrani, Humberto Corrêa, Marc-Antoine Crocq, Kevin J. Smith, Michael Hopp, Gill Mundin and M.A. Crocq and has published in prestigious journals such as Biological Psychiatry, Annals of the New York Academy of Sciences and Neuroscience.

In The Last Decade

Paul Bailey

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Bailey France 19 458 259 251 194 190 44 1.3k
Yuji Kitaichi Japan 19 421 0.9× 198 0.8× 267 1.1× 261 1.3× 198 1.0× 46 1.2k
Joseph Thavundayil Canada 21 335 0.7× 385 1.5× 159 0.6× 174 0.9× 161 0.8× 47 1.3k
I. N. Ferrier United Kingdom 12 306 0.7× 567 2.2× 229 0.9× 205 1.1× 268 1.4× 18 1.4k
J. Fritze Germany 17 368 0.8× 428 1.7× 174 0.7× 133 0.7× 404 2.1× 56 1.4k
Christopher Gottschalk United States 17 467 1.0× 266 1.0× 306 1.2× 173 0.9× 291 1.5× 30 1.2k
Julie Taubman United States 8 655 1.4× 312 1.2× 294 1.2× 215 1.1× 466 2.5× 10 1.5k
H.G.M. Westenberg Netherlands 15 316 0.7× 231 0.9× 157 0.6× 126 0.6× 293 1.5× 36 1.0k
Christian Kissling Germany 14 316 0.7× 233 0.9× 237 0.9× 120 0.6× 264 1.4× 18 1.2k
Larry J. Siever United States 11 215 0.5× 366 1.4× 175 0.7× 170 0.9× 339 1.8× 11 1.0k
Sarah F. B. McTavish United Kingdom 17 538 1.2× 179 0.7× 398 1.6× 90 0.5× 85 0.4× 31 1.2k

Countries citing papers authored by Paul Bailey

Since Specialization
Citations

This map shows the geographic impact of Paul Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bailey more than expected).

Fields of papers citing papers by Paul Bailey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bailey. The network helps show where Paul Bailey may publish in the future.

Co-authorship network of co-authors of Paul Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Bailey. A scholar is included among the top collaborators of Paul Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Bailey. Paul Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Kevin J., Michael Hopp, Gill Mundin, et al.. (2012). Low absolute bioavailability of oral naloxone in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 50(5). 360–367. 81 indexed citations
2.
Smith, Kevin J., Michael Hopp, Gill Mundin, et al.. (2008). Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers. Clinical Therapeutics. 30(11). 2051–2068. 41 indexed citations
3.
Crocq, Marc-Antoine, et al.. (2007). Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets. European Psychiatry. 22(7). 453–454. 18 indexed citations
4.
Crocq, Marc‐Antoine, et al.. (2006). Nicotine dependence and self-esteem in adolescents with mental disorders. Addictive Behaviors. 32(4). 758–764. 23 indexed citations
5.
Duval, Fabrice, Marc-Antoine Crocq, Marie‐Claude Mokrani, et al.. (2004). Increased Adrenocorticotropin Suppression after Dexamethasone Administration in Sexually Abused Adolescents with Posttraumatic Stress Disorder. Annals of the New York Academy of Sciences. 1032(1). 273–275. 24 indexed citations
6.
Bailey, Paul, et al.. (2003). A New Tool for Analysis of Cleanup Criteria Decisions. Health Physics. 85(2 Suppl). S25–S30. 2 indexed citations
7.
Duval, Fabrice, Marie‐Claude Mokrani, José Antonio Monreal, et al.. (2003). Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests. Psychoneuroendocrinology. 28(5). 627–642. 17 indexed citations
8.
Corrêa, Humberto, Fabrice Duval, Marie‐Claude Mokrani, et al.. (2002). Serotonergic function and suicidal behavior in schizophrenia. Schizophrenia Research. 56(1-2). 75–85. 31 indexed citations
9.
Duval, Fabrice, Marie‐Claude Mokrani, Humberto Corrêa, et al.. (2001). Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology. 26(5). 521–537. 40 indexed citations
10.
Corrêa, Humberto, Fabrice Duval, Paul Bailey, et al.. (2001). Noradrenergic dysfunction and antidepressant treatment response. European Neuropsychopharmacology. 11(2). 163–168. 16 indexed citations
11.
Staner, Luc, Fabrice Duval, Marie‐Claude Mokrani, et al.. (2001). Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 25(3). 534–547. 13 indexed citations
12.
Trémeau, Fabien, Luc Staner, Fabrice Duval, et al.. (2001). Suicidal behavior in schizophrenia and family history of suicide. Dialogues in Clinical Neuroscience. 3(2). 120–121. 6 indexed citations
13.
Corrêa, Humberto, Fabrice Duval, Marie‐Claude Mokrani, et al.. (2000). Prolactin response to d-fenfluramine and suicidal behavior in depressed patients. Psychiatry Research. 93(3). 189–199. 53 indexed citations
14.
Duval, Fabrice, et al.. (2000). Multihormonal responses to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology. 25(7). 741–752. 31 indexed citations
15.
Duval, Fabrice, Marie‐Claude Mokrani, Marc‐Antoine Crocq, et al.. (2000). Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(2). 207–225. 32 indexed citations
16.
Duval, Fabrice, et al.. (1999). Thyroid axis activity and serotonin function in major depressive episode. European Neuropsychopharmacology. 9. 236–237. 1 indexed citations
17.
Bailey, Paul. (1997). Costing pathology services: A practical approach to a difficult problem. Pathology. 29(2). 196–200. 3 indexed citations
18.
Duval, Fabrice, et al.. (1997). Dopamine function and HPA axis activity in psychotic depression. Biological Psychiatry. 42(1). 111S–112S. 1 indexed citations
19.
Duval, Fabrice, et al.. (1995). Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology. 20(4). 365–375. 38 indexed citations
20.
Duval, Fabrice, et al.. (1993). Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Psychopharmacology. 110(1-2). 177–180. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026